Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk - PubMed (original) (raw)
Comparative Study
doi: 10.1038/ng.3004. Epub 2014 Jun 8.
Veryan Codd 2, Ivan V Smirnov 3, Terri Rice 4, Paul A Decker 5, Helen M Hansen 4, Thomas Kollmeyer 6, Matthew L Kosel 5, Annette M Molinaro 3, Lucie S McCoy 4, Paige M Bracci 7, Belinda S Cabriga 4, Melike Pekmezci 8, Shichun Zheng 4, Joseph L Wiemels 9, Alexander R Pico 10, Tarik Tihan 8, Mitchell S Berger 3, Susan M Chang 3, Michael D Prados 3, Daniel H Lachance 11, Brian Patrick O'Neill 11, Hugues Sicotte 5, Jeanette E Eckel-Passow 5; ENGAGE Consortium Telomere Group; Pim van der Harst 12, John K Wiencke 13, Nilesh J Samani 2, Robert B Jenkins 6, Margaret R Wrensch 13
Collaborators, Affiliations
- PMID: 24908248
- PMCID: PMC4074274
- DOI: 10.1038/ng.3004
Comparative Study
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
Kyle M Walsh et al. Nat Genet. 2014 Jul.
Abstract
Glioma, the most common central nervous system cancer in adults, has poor prognosis. Here we identify a new SNP associated with glioma risk, rs1920116 (near TERC), that reached genome-wide significance (Pcombined = 8.3 × 10(-9)) in a meta-analysis of genome-wide association studies (GWAS) of high-grade glioma and replication data (1,644 cases and 7,736 controls). This region has previously been associated with mean leukocyte telomere length (LTL). We therefore examined the relationship between LTL and both this new risk locus and other previously established risk loci for glioma using data from a recent GWAS of LTL (n = 37,684 individuals). Alleles associated with glioma risk near TERC and TERT were strongly associated with longer LTL (P = 5.5 × 10(-20) and 4.4 × 10(-19), respectively). In contrast, risk-associated alleles near RTEL1 were inconsistently associated with LTL, suggesting the presence of distinct causal alleles. No other risk loci for glioma were associated with LTL. The identification of risk alleles for glioma near TERC and TERT that also associate with telomere length implicates telomerase in gliomagenesis.
Figures
Figure 1. SNP association plots for high-grade glioma risk and mean leukocyte telomere length at 3q26.2 (TERC), 5p15.33 (TERT), and 20q13.33 (RTEL1)
Telomere associations (grey squares) are from the telomere length genome-wide association meta-analysis (N=37684). Glioma associations (red circles) are from the genome-wide discovery meta-analysis, combining data from the UCSF Adult Glioma Study, The Cancer Genome Atlas, and the Wellcome Trust Case-Control Consortium (N=1013 cases and 6595 controls). Red diamonds are from the combined glioma discovery and UCSF and Mayo Clinic replication analyses (1644 cases, 7736 controls).
Figure 2. SNP association plots indicating the –log10_P_ for association with high-grade glioma risk (y-axis) and mean leukocyte telomere length (x-axis)
Colors correspond to whether the glioma risk allele is associated with longer (blue) or shorter (orange) leukocyte telomere length.
References
- Stupp R, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66. -PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA139020/CA/NCI NIH HHS/United States
- R01CA126831/CA/NCI NIH HHS/United States
- U58DP003862-01/DP/NCCDPHP CDC HHS/United States
- HHSN261201000140C/CA/NCI NIH HHS/United States
- P50 CA108961/CA/NCI NIH HHS/United States
- RC1NS068222Z/NS/NINDS NIH HHS/United States
- R25 CA112355/CA/NCI NIH HHS/United States
- R01 CA126831/CA/NCI NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- UL1RR024131/RR/NCRR NIH HHS/United States
- P30CA15083/CA/NCI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- R01 CA052689/CA/NCI NIH HHS/United States
- BHF_/British Heart Foundation/United Kingdom
- RC1 NS068222/NS/NINDS NIH HHS/United States
- R25CA112355/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- P50CA097257/CA/NCI NIH HHS/United States
- HHSN261201000035C/PC/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- P50CA108961/CA/NCI NIH HHS/United States
- R01CA139020/CA/NCI NIH HHS/United States
- R01CA52689/CA/NCI NIH HHS/United States
- U58 DP003862/DP/NCCDPHP CDC HHS/United States
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources